Quantitative Aspects of Screening Michael OReilly, MD, MPH - - PowerPoint PPT Presentation

quantitative aspects of screening
SMART_READER_LITE
LIVE PREVIEW

Quantitative Aspects of Screening Michael OReilly, MD, MPH - - PowerPoint PPT Presentation

Quantitative Aspects of Screening Michael OReilly, MD, MPH Technical Advisor Field Epidemiology Training Program - Thailand Objectives Understand the concepts of sensitivity, specificity, and predictive values Be able to calculate


slide-1
SLIDE 1

Quantitative Aspects of Screening

Michael O’Reilly, MD, MPH Technical Advisor Field Epidemiology Training Program - Thailand

slide-2
SLIDE 2

Objectives

  • Understand the concepts of sensitivity,

specificity, and predictive values

  • Be able to calculate the testing

characteristics above

  • Know what factors drive predictive values
slide-3
SLIDE 3

Questions

  • How do we evaluate the ability of a

test to “do what it’s supposed to do?”

  • How well does it identify those who

have disease

  • How well does it exclude those who

don’t have disease

slide-4
SLIDE 4

Sensitivity Sensitivity

What is the definition?

slide-5
SLIDE 5

a (true +) b (false +) c (false -) d (true -) Disease

+

  • Test

+

slide-6
SLIDE 6

Sensitivity Sensitivity

The likelihood of a person with disease having a positive test:

_a_ a + c

slide-7
SLIDE 7

a (true +) b (false +) c (false -) d (true -) Disease

+

  • Test

+

slide-8
SLIDE 8

Sensitivity Sensitivity

This is a vertical property I mmutable Concerned only with individuals who have disease

slide-9
SLIDE 9

117 48 33 102 Influenza

+

  • Rapid

Test

+

slide-10
SLIDE 10

117 48 33 102 Influenza

+

  • Rapid

Test

+

  • Sens = ?
slide-11
SLIDE 11

117 48 33 102 Influenza

+

  • Rapid

Test

+

  • Sens =

117/150 = 78%

slide-12
SLIDE 12

Sensitivity Sensitivity

I s it affected by prevalence? What happens if we double the number of individuals with flu in our study?

slide-13
SLIDE 13

234 48 66 102 Influenza

+

  • Rapid

Test

+

  • Sens =

234/300 = 78%

slide-14
SLIDE 14

Specificity Specificity

What is the definition?

slide-15
SLIDE 15

Specificity Specificity

The likelihood of a person without disease having a negative test:

_d_ d + b

slide-16
SLIDE 16

a (true +) b (false +) c (false -) d (true -) Disease

+

  • Test

+

slide-17
SLIDE 17

Specificity Specificity

This is a vertical property I mmutable Concerned only with individuals who don’t have disease

slide-18
SLIDE 18

117 48 33 102 Influenza

+

  • Rapid

Test

+

  • Spec = ?
slide-19
SLIDE 19

117 48 33 102 Influenza

+

  • Rapid

Test

+

  • Spec =

102/150 = 67%

slide-20
SLIDE 20

Relationship of Sensitivity and Relationship of Sensitivity and Specificity Specificity

How are these two characteristics related? Under ordinary circumstances, what happens to specificity if you increase sensitivity?

slide-21
SLIDE 21

MI patients non MI patients

CK MB band

Sensitivity & Specificity: Establishing a Threshold Value

8.0

*

* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *

slide-22
SLIDE 22

1 - specificity sensitivity

Sensitivity & Specificity are Inversely Related

slide-23
SLIDE 23

MI patients non MI patients

CK MB band

Sensitivity & Specificity: Establishing a Threshold Value

8.0

*

* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *

slide-24
SLIDE 24

MI patients non MI patients

CK MB band

Maximizing Sensitivity

4.0

*

* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *

slide-25
SLIDE 25

1 - specificity sensitivity

Gains in Sensitivity mean losses in Specificity

slide-26
SLIDE 26

MI patients non MI patients

CK MB band

Sensitivity & Specificity: Changing Threshold Values

12.0

*

* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *

slide-27
SLIDE 27

1 - specificity sensitivity

Gains in Specificity mean losses in Sensitivity

slide-28
SLIDE 28

Positive Predictive Value Positive Predictive Value

What is the definition?

slide-29
SLIDE 29

Positive Predictive Value Positive Predictive Value

The likelihood of a person with positive test really having disease:

_a_ a + b

slide-30
SLIDE 30

a (true +) b (false +) c (false -) d (true -) Disease

+

  • Test

+

slide-31
SLIDE 31

117 48 33 102 Influenza

+

  • Rapid

Test

+

  • PPV = ?
slide-32
SLIDE 32

117 48 33 102 Influenza

+

  • Rapid

Test

+

  • PPV

=117/165 =71%

slide-33
SLIDE 33

Positive Predictive Value Positive Predictive Value

I s it affected by prevalence? What happens if we double the number of individuals with flu in our study?

slide-34
SLIDE 34

234 48 66 102 Influenza

+

  • Rapid

Test

+

  • PPV

= 234/282 = 83%

slide-35
SLIDE 35

Positive Predictive Value Positive Predictive Value

This is a horizontal property Mutable Concerned both with individuals who have and don’t have disease

slide-36
SLIDE 36

Positive Predictive Value: Example Positive Predictive Value: Example

You are offered a PSA test with sensitivity 90% and specificity 80% I n a cancer clinic population of 1,000 prevalence is 75% . What is PPV? I n an asymptomatic population of 1,000 prevalence is .5% . What is the PPV? Where do you use the test?

slide-37
SLIDE 37

a b c d Prostate Cancer

+

  • PSA

Test

+

  • Total = 1,000
slide-38
SLIDE 38

a b c d Prostate Cancer

+

  • PSA

Test

+

  • Total = 1,000

Prevalence: 75% 1,000 x .75 = 750 a + c = 750 750

slide-39
SLIDE 39

a b c d Prostate Cancer

+

  • PSA

Test

+

  • Total = 1,000

a + c = 750 d + b = 1,000 - 750 = 250 750 250

slide-40
SLIDE 40

675

b

75

d Prostate Cancer

+

  • PSA

Test

+

  • Total = 1,000

Sensitivity = .90 a = 750 x .90 =675 [c = 750 – 675] 750 250

slide-41
SLIDE 41

675 50 75 200

Prostate Cancer

+

  • PSA

Test

+

  • Total = 1,000

Specificity = .80 d = 250 x .80 =200 [b = 250 – 200] 750 250

slide-42
SLIDE 42

675 50 75 200

Prostate Cancer

+

  • PSA

Test

+

  • Total = 1,000

PPV = a/a+b a + b = 725 PPV = 675/725 = 93% 750 250

slide-43
SLIDE 43

4.5 199 0.5 796

Prostate Cancer

+

  • PSA

Test

+

  • Total = 1,000

a + b = 203.5 PPV = 2.2% 5 995

slide-44
SLIDE 44

Positive Predictive Value: Positive Predictive Value: Comments Comments

Affected greatly by prevalence One other factor has a great impact: is it sensitivity or specificity?

slide-45
SLIDE 45

PPV: I nfluence of sensitivity and PPV: I nfluence of sensitivity and specificity specificity

I n a general population of 1,000 prevalence

  • f prostate cancer is .5%

PSA Laboratories, inc. has heard your criticisms and has made 2 new PSA tests:

  • Super Sensitive PSA [sens= .98; spec= .80]
  • Super Specific PSA [sens= .80; spec= .98]

Which test has the higher PPV?

slide-46
SLIDE 46

4.9 199 0.1 796

Prostate Cancer

+

  • PSA

Test

+

  • Total = 1,000

Super Sensitive Sens .98 Spec .80 PPV = 2.4% 5 995

slide-47
SLIDE 47

4 19.9 1 975.1

Prostate Cancer

+

  • PSA

Test

+

  • Total = 1,000

Super Specific Sens .80 Spec .98 PPV = 16.7% 5 995

slide-48
SLIDE 48

PPV: Summary PPV: Summary

Driven by specificity and prevalence Most powerful in settings of moderate disease prevalence

Can describe screening results more powerfully than sensitivity or specificity

slide-49
SLIDE 49

A

(true +)

b

(false +)

C

(false -)

d

(true -) Disease highly prevalent

+

  • Test

+

slide-50
SLIDE 50

a (true +)

b

(false +) c (false -)

D

(true -) Test highly specific

+

  • Test

+

slide-51
SLIDE 51

Testing Characteristics Testing Characteristics

What property is most important for a pregnancy test?

What property is most important for a confirmatory colon cancer test?